Pemphigus Foliaceus-Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report

被引:5
作者
Kraft, Magdalena [1 ]
Worm, Margitta [1 ]
机构
[1] Charite Univ Med Berlin, Allergy Ctr Charite, Dept Dermatol Venerol & Allergol, Berlin, Germany
关键词
pemphigus foliaceus; rituximab; anti-CD20; b-cell depletion; autoimmune blistering diseases; TERM-FOLLOW-UP; DOSE RITUXIMAB; SINGLE-CENTER; VULGARIS; THERAPY; PROTOCOL;
D O I
10.3389/fmed.2018.00315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pemphigus foliaceus is an autoimmune skin disease mediated by autoantibodies directed against desmoglein-1 located in the upper epidermal layer. Rituximab, a monoclonal anit-CD20 antibody depleting b-cells, offers an effective treatment possibility for therapy-resistant pemphigus foliaceus. Here, we present the case of 55-year-old man who did not respond sufficiently to conventional treatment with prednisolone, azathioprine, and cyclophosphamide, but underwent almost complete remission after rituximab treatment. The patient relapsed 7 years later, and a repeated course of rituximab infusions led to a partial remission.
引用
收藏
页数:4
相关论文
共 24 条
[1]   First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up [J].
Ahmed, A. Razzaque ;
Nguyen, Tegan ;
Kaveri, Srini ;
Spigelman, Zachary S. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 34 :25-31
[2]   A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab [J].
Ahmed, A. Razzaque ;
Shetty, Shawn .
AUTOIMMUNITY REVIEWS, 2015, 14 (04) :323-331
[3]   Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions [J].
Alaibac, Mauro .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[4]   Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up [J].
Cianchini, Giuseppe ;
Lupi, Francesca ;
Masini, Cinzia ;
Corona, Rosamaria ;
Puddu, Pietro ;
De Pita, Ornella .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) :617-622
[5]   Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response [J].
Colliou, Natacha ;
Picard, Damien ;
Caillot, Frederique ;
Calbo, Sebastien ;
Le Corre, Stephanie ;
Lim, Annick ;
Lemercier, Brigitte ;
Le Mauff, Brigitte ;
Maho-Vaillant, Maud ;
Jacquot, Serge ;
Bedane, Christophe ;
Bernard, Philippe ;
Caux, Frederic ;
Prost, Catherine ;
Delaporte, Emmanuel ;
Doutre, Marie-Sylvie ;
Dreno, Brigitte ;
Franck, Nathalie ;
Ingen-Housz-Oro, Saskia ;
Chosidow, Olivier ;
Pauwels, Christine ;
Picard, Catherine ;
Roujeau, Jean-Claude ;
Sigal, Michele ;
Tancrede-Bohin, Emmanuelle ;
Templier, Isabelle ;
Eming, Ruediger ;
Hertl, Michael ;
D'Incan, Michel ;
Joly, Pascal ;
Musette, Philippe .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (175)
[6]   Rituximab therapy in pemphigus foliaceus: report of 12 cases and review of recent literature [J].
de Sena Nogueira Maehara, L. ;
Huizinga, J. ;
Jonkman, M. F. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (05) :1420-1423
[7]   S2k Guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid [J].
Eming, Ruediger ;
Sticherling, Michael ;
Hofmann, Silke C. ;
Hunzelmann, Nicolas ;
Kern, Johannes S. ;
Kramer, Harald ;
Pfeiffer, Christiane ;
Schuster, Volker ;
Zillikens, Detlef ;
Goebeler, Matthias ;
Hertl, Michael ;
Nast, Alexander ;
Orzechowski, Hans-Dieter ;
Sardy, Miklos ;
Schmidt, Enno ;
Sitaru, Cassian ;
Sporbeck, Birte ;
Worm, Margitta .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (08) :833-845
[8]   Pilot Study of 19 Patients with Severe Pemphigus: Prophylactic Treatment with Rituximab Does Not Appear to be Beneficial [J].
Gregoriou, S. ;
Giatrakou, S. ;
Theodoropoulos, K. ;
Katoulis, A. ;
Loumou, P. ;
Toumbis-Ioannou, E. ;
Papadavid, E. ;
Avgerinou, G. ;
Stavrianeas, N. ;
Rigopoulos, D. .
DERMATOLOGY, 2014, 228 (02) :158-165
[9]   Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol [J].
Heelan, Kara ;
Al-Mohammedi, Faisal ;
Smith, Myles J. ;
Knowles, Sandra ;
Lansang, Perla ;
Walsh, Scott ;
Shear, Neil H. .
JAMA DERMATOLOGY, 2014, 150 (07) :703-708
[10]   Low-dose rituximab is effective in pemphigus [J].
Horvath, B. ;
Huizinga, J. ;
Pas, H. H. ;
Mulder, A. B. ;
Jonkman, M. F. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) :405-412